Related Experiment Video
Updated: May 20, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Fetal evaluation of the modified-myocardial performance index in pregnancies complicated by diabetes
Horacio Figueroa1, Maria Carolna Silva, Cristian Kottmann
1Department of Obstetrics & Gynecology and Laboratory of Reproductive Biology, Universidad de Los Andes, Chile. horaciofigueroa@miuandes.cl
Objective:
To evaluate the fetal cardiac function by modified myocardial performance index (Mod-MPI) in pregnant diabetic patients.
Methods:
Modified myocardial performance index was measured in fetuses of patients with diabetes (DM) between 30 and 40 weeks of gestation. The isovolumetric contraction time, isovolumetric relaxation time and ejection time were measured. Mod-MPI was calculated as (isovolumetric contraction time + isovolumetric relaxation time)/ejection time. Results were analyzed by using one-way analysis of variance (post hoc Bonferroni correction), Chi-square and Student's test.
Results:
Modified myocardial performance index values of fetuses from DM mothers were significantly higher than controls (0.43 vs 0.37, P < 0.0001), and it was not different between gestational versus pregestational DM (0.42 vs 0.45, P = 0.18). Mod-MPI was also higher in the presence of polyhydramnios (0.49 vs 0.41, P < 0.0001), insulin use (0.46 vs 0.40, P < 0.05), and large for gestational age fetuses (0.49 vs 0.40, P < 0.0001). There were no significant differences in Mod-MPI between newborns with versus without neonatal complications such as hypoglycemia or polycythemia.
Conclusions:
In fetuses of DM mothers, evaluation of the Mod-MPI identifies those with worse maternal disease and large fetal size.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Mitral Valve Prolapse III: Nursing Management
Complications of Diabetes Mellitus
Cardiomyopathy II: Dilated Cardiomyopathy
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

